Sorted by popular

Long-term efficacy for lebrikizumab seen in moderate, severe eczema

For patients with moderate-to-severe atopic dermatitis (AD), lebrikizumab has long-term efficacy, according to a study presented at the annual meeting of the European Academy of Dermatology and Venereology, held from Sept. ...